ArticleJournal of experimental & clinical cancer research : CR2022

Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.

Iris C Salaroglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.